Cargando…
Anti-SARS-CoV2 antibody-mediated cytokine release syndrome in a patient with acute promyelocytic leukemia
BACKGROUND: Passive immunization against SARS-CoV-2 limits viral burden and death from COVID-19; however, it poses a theoretical risk of disease exacerbation through antibody-dependent enhancement (ADE). ADE after anti-SARS-CoV2 antibody treatment has not been reported, and therefore the potential r...
Autores principales: | Hegazy, Ahmed N., Krönke, Jan, Angermair, Stefan, Schwartz, Stefan, Weidinger, Carl, Keller, Ulrich, Treskatsch, Sascha, Siegmund, Britta, Schneider, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188919/ https://www.ncbi.nlm.nih.gov/pubmed/35692034 http://dx.doi.org/10.1186/s12879-022-07513-0 |
Ejemplares similares
-
Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
por: Leistner, Rasmus, et al.
Publicado: (2022) -
COVID-19—from mucosal immunology to IBD patients
por: Weidinger, Carl, et al.
Publicado: (2021) -
Identification of Perioperative Procedural and Hemodynamic Risk Factors for Developing Colonic Ischemia after Ruptured Infrarenal Abdominal Aortic Aneurysm Surgery: A Single-Centre Retrospective Cohort Study
por: Omran, Safwan, et al.
Publicado: (2023) -
Acute Promyelocytic Leukemia
por: Thomas, Xavier, et al.
Publicado: (2020) -
Anti-Adhesion Therapies in Inflammatory Bowel Disease—Molecular and Clinical Aspects
por: Zundler, Sebastian, et al.
Publicado: (2017)